ID   TPP2_RAT                Reviewed;        1249 AA.
AC   Q64560;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 163.
DE   RecName: Full=Tripeptidyl-peptidase 2;
DE            Short=TPP-2;
DE            EC=3.4.14.10 {ECO:0000250|UniProtKB:P29144};
DE   AltName: Full=Tripeptidyl aminopeptidase;
DE   AltName: Full=Tripeptidyl-peptidase II;
DE            Short=TPP-II;
GN   Name=Tpp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8602240; DOI=10.1038/380403a0;
RA   Rose C., Vargas F., Facchinetti P., Bourgeat P., Bambal R.B., Bishop P.B.,
RA   Chan S.M., Moore A.N., Ganellin C.R., Schwartz J.C.;
RT   "Characterization and inhibition of a cholecystokinin-inactivating serine
RT   peptidase.";
RL   Nature 380:403-409(1996).
CC   -!- FUNCTION: Cytosolic tripeptidyl-peptidase that releases N-terminal
CC       tripeptides from polypeptides and is a component of the proteolytic
CC       cascade acting downstream of the 26S proteasome in the ubiquitin-
CC       proteasome pathway. It plays an important role in intracellular amino
CC       acid homeostasis (By similarity). Stimulates adipogenesis (By
CC       similarity). {ECO:0000250|UniProtKB:P29144,
CC       ECO:0000250|UniProtKB:Q64514}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of an N-terminal tripeptide from a polypeptide.;
CC         EC=3.4.14.10; Evidence={ECO:0000250|UniProtKB:P29144};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Translocates to the
CC       nucleus in response to gamma-irradiation. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The limitation of proteolytic products to tripeptides is
CC       achieved by tailoring the size of the substrate-binding cleft: the two
CC       negatively charged residues Glu-305 and Glu-331 that are blocking
CC       position P4 limit the number of residues that can be accommodated in
CC       the binding cleft and thus create a molecular ruler. At the same time,
CC       they orient substrates so that the tripeptides are removed exclusively
CC       from the N-terminus (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U50194; AAA93458.1; -; mRNA.
DR   PIR; S68431; S68431.
DR   RefSeq; NP_112399.1; NM_031137.1.
DR   AlphaFoldDB; Q64560; -.
DR   SMR; Q64560; -.
DR   BioGRID; 249673; 1.
DR   IntAct; Q64560; 18.
DR   STRING; 10116.ENSRNOP00000074045; -.
DR   BindingDB; Q64560; -.
DR   ChEMBL; CHEMBL4675; -.
DR   MEROPS; S08.A56; -.
DR   iPTMnet; Q64560; -.
DR   PhosphoSitePlus; Q64560; -.
DR   jPOST; Q64560; -.
DR   PaxDb; 10116-ENSRNOP00000015393; -.
DR   GeneID; 81815; -.
DR   KEGG; rno:81815; -.
DR   UCSC; RGD:621584; rat.
DR   AGR; RGD:621584; -.
DR   CTD; 7174; -.
DR   RGD; 621584; Tpp2.
DR   VEuPathDB; HostDB:ENSRNOG00000011194; -.
DR   eggNOG; KOG1114; Eukaryota.
DR   InParanoid; Q64560; -.
DR   OrthoDB; 2441948at2759; -.
DR   BRENDA; 3.4.14.10; 5301.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   PRO; PR:Q64560; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000011194; Expressed in esophagus and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004177; F:aminopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0042277; F:peptide binding; IDA:RGD.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008240; F:tripeptidyl-peptidase activity; IDA:RGD.
DR   GO; GO:0080144; P:intracellular amino acid homeostasis; ISO:RGD.
DR   GO; GO:0030163; P:protein catabolic process; IDA:RGD.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd04857; Peptidases_S8_Tripeptidyl_Aminopeptidase_II; 1.
DR   Gene3D; 1.25.40.710; -; 1.
DR   Gene3D; 2.60.40.3170; -; 1.
DR   Gene3D; 6.10.250.3080; -; 1.
DR   Gene3D; 3.40.50.200; Peptidase S8/S53 domain; 2.
DR   InterPro; IPR000209; Peptidase_S8/S53_dom.
DR   InterPro; IPR036852; Peptidase_S8/S53_dom_sf.
DR   InterPro; IPR022398; Peptidase_S8_His-AS.
DR   InterPro; IPR023828; Peptidase_S8_Ser-AS.
DR   InterPro; IPR050131; Peptidase_S8_subtilisin-like.
DR   InterPro; IPR015500; Peptidase_S8_subtilisin-rel.
DR   InterPro; IPR034051; TPP_II_domain.
DR   InterPro; IPR022232; TPPII_C_art.
DR   InterPro; IPR046939; TPPII_C_sf.
DR   InterPro; IPR048384; TPPII_GBD.
DR   InterPro; IPR048383; TPPII_Ig-like-1.
DR   InterPro; IPR022229; TPPII_Ig-like-2.
DR   InterPro; IPR046940; TPPII_Ig-like_sf.
DR   PANTHER; PTHR43806; PEPTIDASE S8; 1.
DR   PANTHER; PTHR43806:SF14; TRIPEPTIDYL-PEPTIDASE 2; 1.
DR   Pfam; PF00082; Peptidase_S8; 1.
DR   Pfam; PF12580; TPPII; 1.
DR   Pfam; PF12583; TPPII_C; 1.
DR   Pfam; PF21316; TPPII_GBD; 1.
DR   Pfam; PF21223; TPPII_Ig-like-1; 1.
DR   PRINTS; PR00723; SUBTILISIN.
DR   SUPFAM; SSF52743; Subtilisin-like; 1.
DR   PROSITE; PS51892; SUBTILASE; 1.
DR   PROSITE; PS00137; SUBTILASE_HIS; 1.
DR   PROSITE; PS00138; SUBTILASE_SER; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Aminopeptidase; Cytoplasm; Hydrolase; Nucleus; Phosphoprotein;
KW   Protease; Reference proteome; Serine protease.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P29144"
FT   CHAIN           2..1249
FT                   /note="Tripeptidyl-peptidase 2"
FT                   /id="PRO_0000076424"
FT   DOMAIN          9..508
FT                   /note="Peptidase S8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   REGION          998..1018
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1001..1018
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        44
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        264
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        449
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P29144"
FT   MOD_RES         401
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64514"
FT   MOD_RES         915
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29144"
SQ   SEQUENCE   1249 AA;  138293 MW;  F4A41664028AAB2B CRC64;
     MATAATEEPF PFHGLLPKKE TGASSFLCRY PEYDGRGVLI AVLDTGVDPG APGMQVTTDG
     KPKIIDIIDT TGSGDVNTAT EVEPKDGEIT GLSGRVLKIP ANWTNPSGKY HIGIKNGYDF
     YPKALKERIQ KERKEKIWDP IHRVALAEAC RKQEEFDIAN NGSSQANKLI KEELQSQVEL
     LNSFEKKYSD PGPVYDCLVW HDGETWRACV DSNENGDLGK STVLRNYKEA QEYGSFGTAE
     MLNYSVNIYD DGNLLSIVTS GGAHGTHVAS IAAGHFPEEP ERNGVAPGAQ ILSIKIGDTR
     LSTMETGTGL IRAMIEVINH KCDLVNYSYG EATHWPNSGR ICEVINEAVW KHNTIYVSSA
     GNNGPCLSTV GCPGGTTSSV IGVGAYVSPD MMVAEYSLRE KLPANQYTWS SRGPSADGAL
     GVSISAPGGA IASVPNWTLR GTQLMNGTSM SSPNACGGIA LVLSGLKANN VDYTVHSVRR
     ALENTAIKAD NIEVFAQGHG IIQVDKAYDY LIQNTSFANR LGFTVTVGNN RGIYLRDPVQ
     VAAPSDHGVG IEPVFPENTE NSEKISFQLH LALTSNSSWV QCPSHLELMN QCRHINIRVD
     PRGLREGLHY TEVCGYDIAS PNAGPLFRVP ITAVIAAKVN ESSHYDLAFT DVHFKPGQIR
     RHFVEVPEGA TWAEVTVCSC SSEVSAKFVL HAVQLVKQRA YRSHEFYKFC SLPEKGTLIE
     AFPVLGGKAI EFCIARWWAS LSDVNIDYTI SFHGIVCTAP QLNIHASEGI NRFDVQSSLK
     YEDLAPCITL KSWVQTLRPV NAKTRPLGSR DVLPNNRQLY EMVLTYSFHQ PKSGEVTPSC
     PLLCELLYES EFDSQLWIIF DQNKRQMGSG DAYPHQYSLK LEKGDYTIRL QIRHEQISDL
     DRLKDLPFIV SHRLSNTLSL DIHENHSLAL LGKKKSSSLT LPPKYNQPFF VTSLPDDKIP
     KGAGPGCYLA GSLTLSKTEL GKKADVIPVH YYLIPPPTKT KNGSKDKEKD SEKEKDLKEE
     FTEALRDLKI QWMTKLDSTD IYNELKETYP AYLPLYVARL HQLDAEKERM KRLNEIVDAA
     NAVISHIDQT ALAVYIAMKT DPRPDAATIK NDMDKQKSTL VDALCRKGCA LADHLLHAQP
     HDGAAAGDAE AKEEEGESTL ESLSETYWET TKWTDLFDTK VLTFAYKHAL VNKMYGRGLK
     FATKLVEEKP TKENWKNCIQ LMKLLGWTHC ASFTENWLPI MYPPDYCVF
//
